Dacarbazine

This classification denotes a triazene compound with the molecular formula C6H10N6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7GR28W0FJI, chemically known as 5-(3,3-dimethyltriaz-1-en-1-yl)-1h-imidazole-4-carboxamide but more generally known as dacarbazine, which bears US NIH Compound Identifier 5281007. European Medicines Agency schedules Dacarbazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06882MIG. The term DACARBAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules dacarbazine in its Anatomical Therapeutic Chemical (ATC) Classification. DACARBAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule dacarbazine under HS 29332990 and SITC 51573. As of Q4 2014, DACARBAZINE remains US FDA's Preferred Term for this commodity. Dacarbazine bears US NLM identifiers UMLS ID C0010927 and NCI Concept Code C411. SMILES: O=C(N)C1=NC=N/C1=N\NN(C)C.